Detecting and analyzing severe pneumonia in critically ill patients
Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients
This study looks at patients in the ICU with severe pneumonia to see how different types of pneumonia affect their treatment and recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 16 Years and up |
| Sex | All |
| Sponsor | Asan Medical Center Academic / other |
| Locations | 1 site (Seoul) |
| Trial ID | NCT01068990 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients admitted to the medical intensive care unit (ICU) with severe pneumonia. It aims to monitor and analyze both community-acquired and hospital-acquired pneumonia, collecting data on patient demographics, clinical features, microbiological characteristics, and outcomes. The study will provide insights into the characteristics and treatment responses of critically ill patients suffering from lower respiratory infections.
Who should consider this trial
Good fit: Ideal candidates are patients admitted to the medical ICU with pneumonia or those who develop new pneumonia during their stay.
Not a fit: Patients who have been treated for pneumonia for more than 48 hours prior to ICU admission without an isolated causative organism may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the understanding and management of severe pneumonia in critically ill patients.
How similar studies have performed: Other studies have shown success in characterizing pneumonia in ICU settings, making this approach both relevant and tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients admitting medical ICU with pneumonia * Medical ICU admitted patients who is developed new pneumonia Exclusion Criteria: * Patients already treated more than 48 hours for pneumonia in transferring hospital and no causative organism is isolated
Where this trial is running
Seoul
- Asan Medical Center — Seoul, South Korea (Recruiting)
Study contacts
- Principal investigator: Sang-Ho Choi, MD — Asan Medical Center
- Study coordinator: Sang-Ho Choi, MD
- Email: sangho@amc.seoul.kr
- Phone: +82-2-3010-3304
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.